251 related articles for article (PubMed ID: 36255606)
1. Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?
Wang Y; Strazzabosco M; Madoff DC
Curr Oncol Rep; 2022 Dec; 24(12):1741-1750. PubMed ID: 36255606
[TBL] [Abstract][Full Text] [Related]
2. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
Wacker F; Dewald C
Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
[TBL] [Abstract][Full Text] [Related]
4. Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Zhang M; Qi W; Qiu X; Yu C; Qiu W; Wang S; Qiu Z
Radiol Oncol; 2023 Dec; 57(4):419-429. PubMed ID: 38038416
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Sapisochin G; Ivanics T; Heimbach J
Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions.
Kodali S; Connor AA; Thabet S; Brombosz EW; Ghobrial RM
Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):129-138. PubMed ID: 37517983
[TBL] [Abstract][Full Text] [Related]
7. Challenges of surgical management of intrahepatic cholangiocarcinoma.
Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
[TBL] [Abstract][Full Text] [Related]
8. Liver resection and transplantation for intrahepatic cholangiocarcinoma.
Mazzaferro V; Gorgen A; Roayaie S; Droz Dit Busset M; Sapisochin G
J Hepatol; 2020 Feb; 72(2):364-377. PubMed ID: 31954498
[TBL] [Abstract][Full Text] [Related]
9. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.
Nagino M; Kamiya J; Nishio H; Ebata T; Arai T; Nimura Y
Ann Surg; 2006 Mar; 243(3):364-72. PubMed ID: 16495702
[TBL] [Abstract][Full Text] [Related]
10. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma.
Bath NM; Pawlik TM
Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354
[TBL] [Abstract][Full Text] [Related]
11. Current therapy of hilar cholangiocarcinoma.
Lau SH; Lau WY
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):12-7. PubMed ID: 22251465
[TBL] [Abstract][Full Text] [Related]
12. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
Rana A; Hong JC
Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
15. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
Hong K; Geschwind JF
Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
[TBL] [Abstract][Full Text] [Related]
16. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.
Cholangiocarcinoma Working Group
Dig Liver Dis; 2020 Dec; 52(12):1430-1442. PubMed ID: 32952071
[TBL] [Abstract][Full Text] [Related]
17. Locoregional therapy for cholangiocarcinoma.
Kuhlmann JB; Blum HE
Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
[TBL] [Abstract][Full Text] [Related]
18. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.
Soares KC; Jolissaint JS; McIntyre SM; Seier KP; Gönen M; Sigel C; Nasar N; Cercek A; Harding JJ; Kemeny NE; Connell LC; Koerkamp BG; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Wei AC; Jarnagin WR
Cancer Med; 2023 Jun; 12(11):12272-12284. PubMed ID: 37062071
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how.
Achurra P; Fernandes E; O'Kane G; Grant R; Cattral M; Sapisochin G
Curr Opin Organ Transplant; 2024 Apr; 29(2):161-171. PubMed ID: 38258823
[TBL] [Abstract][Full Text] [Related]
20. Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization.
Vogl TJ; Balzer JO; Dette K; Hintze R; Pegios W; Mäurer J; Keck H; Neuhaus P; Felix R
Radiology; 1998 Jul; 208(1):217-22. PubMed ID: 9646816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
